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Abstract Quantitative evaluation of minimal polynucleo-
tide concentrations has become a critical analysis among a
myriad of applications found in molecular diagnostic tech-
nology. Development of high-throughput, nonenzymatic
assays that are sensitive, quantitative and yet feasible for
point-of-care testing are thus beneficial for routine imple-
mentation. Here, we develop a nonenzymatic method for
quantifying surface concentrations of labeled DNA targets
by coupling regulated amounts of polymer growth to
complementary biomolecular binding on array-based bio-
chips. Polymer film thickness measurements in the 20–
220 nm range varylogarithmically with labeledDNA surface
concentrations over two orders of magnitude with a lower
limit of quantitation at 60 molecules/μm
2 (∼10
6 target
molecules). In an effort to develop this amplificationmethod
towards compatibility with fluorescence-based methods of
characterization, incorporation of fluorescent nanoparticles
into the polymer films is also evaluated. The resulting gains
in fluorescent signal enable quantification using detection
instrumentation amenable to point-of-care settings.
Keywords Signalamplification.Moleculardiagnostics.
Quantitative nucleicaciddetection.DNAmicroarrays.
Visiblelightphotopolymerization.Surface-initiated
polymerization
Introduction
Quantitative evaluations of biomolecule concentrations are
becoming increasingly necessary due to the expanding
discovery and characterization of potential disease markers
and the development of their corresponding applications in
molecular diagnostics. Quantitative, sequence-specific anal-
ysis of polynucleotide biomarkers potentially allows for the
monitoring of viral loads, allowing for drug efficacy
evaluation [1, 2], elucidation of various disease states and
progressions [3], and may provide clinical validation of a
diagnosis [4]. Specifically with application to human
cancers, several types of nucleic acid biomarkers require
quantitative analysis, such as evaluation of over- or under-
expressed RNA transcripts, analysis of genomic amplifica-
tions ordeletions,aswellasevaluation ofepigenetic markers
[5, 6]. Mutation detection, traditionally performed on a
qualitative basis, can also benefit from quantitative analysis
through determination of wild-type to mutant-type ratios,
as well as providing distinction between stochastic and
pathogenic mutations [7].
Several challenges for quantitative biomolecular analysis
in molecular diagnostics lie within the prerequisites of
point-of-care implementation, requiring assays that are
rapid and robust, use stable and inexpensive reagents, and
are relatively simple to implement. The determination of
sequence-specific nucleic acid concentrations has been
developed through several PCR-based target amplification
technologies, most notably real-time quantitative PCR [8].
Other technologies aim at achieving quantitative gains from
signal amplification, such as rolling circle amplification [9],
which has been creatively used in combination with
BEAMing for sensitive quantitative detection [10], and
branched DNA technology [11]. While such detection
assays offer sensitive, powerful methods of quantitative
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by expensive and often complex protocols due to their
reliance on enzymes and/or fluorescently labeled oligonu-
cleotides for amplification, or may require instrumentation
beyond the scope of point-of-care settings.
Recently, polymerization-based amplification has been
demonstrated as a rapid, nonenzymatic method of signal
amplification capable of offering visual detection of the
presence of labeled polynucleotide targets on a biochip
surface [12, 13]. With this method, amplification and
detection are achieved by covalently coupling photoinitiator
molecules to streptavidin proteins followed by binding onto
biotinylated oligonucleotide targets immobilized to a bio-
sensor surface. Upon contacting such biochips with mono-
mer and light, a surface-initiated polymerization reaction
occurring exclusively at the binding sites generates high
molecular weight, highly visible polymer films that signal
the binding event. While this method offers high amplifica-
tion factors and sensitive, visual detection of biotinylated
DNA molecules using assay conditions favorable for field
implementation, analysis thus far is largely limited to a
qualitative, positive/negative determination of the presence
of model 3′-biotin-labeled capture sequences.
The purpose of this manuscript is to present a visible
light polymerization-based amplification system that uses
the biofunctional photoinitiator streptavidin-eosin isothio-
cyanate (SA-EITC) as a new method for quantifying surface
concentrations of biotinylated nucleic acid targets. Such
developments towards quantitation will allow for the
implementation of this method in an increased number of
molecular diagnostic applications. The potential for quanti-
tation is investigated using array-based biochips containing
spots with diluted amounts of 3′-biotin-labeled target oligos
such that the amount of amplification as a function of oligo
surface concentration can be determined. This approach of
directly printing the biotinylated targets onto the surface
serves as a model system [14] to evaluate the characteristics
of polymerization-based amplification. Such a system is
representative of a biochip after DNA target labeling with
biotin that may be done either in solution [15] followed by
hybridization to complementary capture probes, or through
on-chip, primer extension labeling performed after comple-
mentaryduplex formation[16–18]. Thus, the surface density
of the biotinylated probe is proportional to the target
solution concentration, dependent on the hybridization
efficiency between a target and its surface-bound, comple-
mentary capture probe (typically, Khyb=10
9 M
−1)[ 19], and
the labeling efficiency.
Incorporation of an amplified fluorescent, radiological,
or chemiluminescent response with polymer film growth is
also desirable due to the numerous types of inexpensive
detection instrumentation consistent with these methods
when signals are large. Fluorescence is particularly desir-
able due to its sensitivity, safety, and multiplexing capabil-
ities, and it is perhaps the most widely accepted method of
detection, as evidenced by the wide number of amplification
methods that aim at achieving large gains in fluorescent
signal [20, 21]. Due to these considerations, fluorescent
moieties are added to monomer formulation to achieve an
amplified, fluorescent signal that correlates with polymer
growth. The amount of amplification from each binding site
with known biotin capture probe density is then deter-
mined, either through direct measurement of film thickness
or by measuring an amplified fluorescent signal, as shown
in Fig. 1.
Experimental
Materials
Aminosilated glass slides were purchased from CEL
Associates (Pearland, TX, USA). Streptavidin (SA) proteins
were purchased from Pierce (Rockford, IL, USA) and
stored at 4 °C until use. Polyethylene glycol diacrylate, Mn=
575 Da (PEGDA), methyl diethanol amine (MDEA), 1-
vinyl-2-pyrrolidinone, dithiothreitol (DTT), 50x Denharts
solution, and Tween 20 were purchased from Sigma (St.
Louis, MO, USA). The fluorescent nanoparticles were
0.02 μm-diameter, carboxy-modified Nile Red FluoSpheres
(Invitrogen, Carlsbad, CA, USA), encapsulating ∼10
2
fluorophores per particle and supplied at a stock concen-
tration of 4.5×10
15 nanoparticles/mL containing 0.1%
sodium azide preservative. The azide preservative was
removed with the use of 100,000 Da dialysis columns
(Spectra-Por, Rancho Dominguez, CA, USA). The purified
FluoSpheres were stored at 4 °C until further use. Capture
oligonucleotede sequences used were obtained from Operon
(Huntsville, AL, USA) and were of the same sequence as
previously reported [13].
Dilution chip fabrication
Dilution chips were fabricated according to a previous
protocol [13]. Dilution chips contain fifteen sets of spots
with different 3’ biotin surface densities that span a range of
three orders of magnitude (10
4 labels/μm
2 to < 5 labels/μm
2).
These chips were originally developed strictly to investigate
sensitivity but were not sufficient for quantitative analysis.
For this study, dilution chips were modified from their
previous version by changing the spotting concentrations of
several intermediate points. The resulting 3’ biotin surface
densities were determined using the calibration of spotting
concentrations with surface densities that was previously
developed [13]. In its current version, a more uniform
distribution of biotin surface densities covering same range
168 R. Hansen et al.is obtained within the array, allowing for a comprehensive
evaluation of polymer growth with surface density.A sample
layout of the new dilution chips and the corresponding
3’ biotin surface densities is displayed in Fig. 2. Dilutions
were spotted on aminosilated glass using a 375 μm
diameter stealth solid pin (ArrayIt, Sunnyvale, CA, USA)
with a VersArray ChipWriter Pro system (Bio-Rad Labora-
tories, Hercules, CA, USA). Arrays were printed with
replicate spots either within the same array or with replicate
spots in an additional array on the same microarray slide.
Functionalization and characterization of dilution chips
with SA-EITC
SA-EITC was synthesized, purified, and characterized
according to a previously published protocol [13]. Dilution
chips were functionalized with SA-EITC by applying a
mixture of unlabeled SA and SA-EITC at 1 μg/mL in a 5X
Denharts, 1 X PBS solution for 30 minutes followed by
rinsingwithwashbuffer(1MNaCl,0.1MTris,0.1%(wt/vol)
T w e e n2 0 ) ,t h e nH 2O, and dried with N2. Preamplified,
SA-EITC functionalized dilution chips were characterized
using the green channel of a microarray scanner at 100%
PMT gain (Agilent, Santa Clara, CA, USA) calibrated
using a Cy3/Cy5 calibration chip (Full Moon Biosystems,
Sunnyvale, CA, USA).
Polymerization-based amplification
Monomer solution contained 434 mM PEGDA, 225 mM
MDEA, and 37 mM 1-vinyl-2-pyrrolidinone in H2O (pH 9).
Fluorescent monomer formulations included the addition of
fluorescent nanoparticles to this monomer formulation at
90 or 500 nM concentrations. Conventional UV-Vis spec-
troscopy was used to measure absorbance from fluorescent
monomer formulations. Monomer was purged with argon
and then 500 μL was contacted with the SA-EITC
functionalized dilution chip surface using a Whatman Chip
Clip (Whatman, Florham Park, NJ, USA). Collimated,
495–650-nm polychromatic light was used to initiate poly-
merization from an Acticure light source (EFOS, Mis-
sissauga, ON, Canada) at an intensity of 10 mW/cm
2,a s
measured by an EFOS Cure-Rite radiometer. This was
achieved with the use of an in-house 350–650-nm internal
interference filterand a 490-nmstopband limit filter(Edmond
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Fig. 2 Dilution chip layout with surface densities (molecules/μm
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3′-biotin-labeled oligonucleotide capture probes on dilution chips. 3′-
biotin-labeled capture probes are diluted into a solution of unlabeled
capture probes such that the overall surface density of capture oligo
remained constant at 1.8×10
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Fig. 1 Dilution chips containing controlled amounts of 3′ biotin
oligonucleotides allow for an evaluation of the quantitative character-
istics of polymerization-based amplification. Amplification is charac-
terized by film thickness through the use of profilometry. In the case
where fluorescent moiety is included in the monomer formulation, the
extent of amplification can also be measured by the fluorescence
intensity using a fluorescence microscope
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collimating lens attached to the end of a light guide. When
fluorescent nanoparticles were included in monomer solu-
tions, light intensity was increased accordingly to account
for light attenuation occurring from the nanoparticles over a
1-mm-thick monomer layer. Prior to light exposure, the
atmosphere was purged with argon for 5 min followed by
light exposure for the desired time period. After amplifica-
tion, unreacted monomer was removed from the surface by
gently rinsing with water.
Rhodamine B coupling into polymer films
In an effort to achieve highly visible polymer films for
visualization with fluorescence microscopy, methacryloxyethyl
thiocarbamoyl rhodamine B (Polysciences, Warrington, PA,
USA) was coupled to pendant double bonds present on PEG
films on a surface through addition reactions with a DTT
linker molecule. A 400 mM solution of DTT was prepared
in 0.1 M carbonate buffer, pH 9.0. The DTT solution was
contacted with the polymer chip for 25 min, followed by
30 min of washing with H2O. A solution of 4 μg/mL
methacryloxyethyl thiocarbamoyl rhodamine B was then
prepared in carbonate buffer and contacted with the DTT
functionalized gel for 30 min, followed by 30 min of
washing in H2O. This coupling procedure was useful as a
method of visualizing polymer films with fluorescence
microscopy, but was not sufficient for use in quantifying
film thicknesses.
Monitoring of bulk polymerization kinetics
The initiating capability of SA-EITC in various monomer
formulations was verified by monitoring bulk polymeriza-
tion kinetics through the use of Fourier transform infrared
(FTIR) spectroscopy (Nicolet Instrument Corporation,
Madison, WI, USA). The conversion rate of carbon–carbon
double bonds in monomer to carbon–carbon single bonds in
polymer was measured by monitoring the absorbance at
6150 to 6212 cm
−1 with time, using monomer formulations
and light intensities identical to those used during on-chip
polymerizations.
Post-amplification characterization of dilution chips
Film thicknesses were measured with a Dektak 6 M
profilometer (Veeco, Plainview, NY, USA) using a 12.5-μm
diamond stylus tip at a stylus force of 1 mg. Brightfield and
fluorescentpictures of amplified dilutionchips wereobtained
through the use of a Leica MZ FLIII stereomicroscope (Leica
Microsystems, Wetzlar, Germany) calibrated with a Cy3/Cy5
calibration chip. Nile Red fluosphere-functionalized poly-
mer films on the surface were further quantified with the
use of an Agilent Technologies microarray scanner (green
channel, PMT 1%).
Results and discussion
Dependence of film thickness on surface oligonucleotide
concentrations
The SA-EITC product has the ability to both initiate free-
radical photopolymerizations by generating radicals
through photoinduced electron transfer reactions with
amine coinitiators, and to retain high-affinity binding to
biotinylated substrates [13]. Upon the functionalization of
a biotinylated dilution chip with SA-EITC, but before ampli-
fication, these dilution chips are imaged with a fluorescence
scanner to verify the allocation of photoinitiators on the
surface at densities proportional to the specific biotin label
densities at each binding site. During amplification, long
exposuretimestolow-intensitylightwereusedtocompletely
degrade SA-EITC, even from the spots containing the lowest
initiator concentrations. This is followed by rapid propaga-
tion reactions of free radicals through monomer to generate
high molecular weight polymer films on the surface. At long
exposure times, long-wave visible light is desired to
minimize or eliminate any nonspecific bulk polymerization
that is characteristically observed from light sources with
emissions in the UV region. Thus, polymerizations using
polychromatic green light from a mercury arc lamp were
performed. By examining several longer exposure times in
the amplification, times of greater than 30 min were found to
be required to obtain maximum sensitivity.
Upon amplification of this system at 30 min, polymer
films generated from as low as 60 biotin markers/μm
2
become visually observable under an optical microscope or
to the unaided eye. Analysis of the film thicknesses at each
siteshowedthatacorrespondingdynamicprofilewasachiev-
able from the range of 60 to 4,700 biotin markers/μm
2. This
was followed by a saturated region from 8,300 to 18,000
biotin markers/μm
2 with film thicknesses all in the 230±
20 nm region, independent of marker density, as shown in
Fig. 3. The dynamic region of amplification, approaching
two orders of magnitude, fits a logarithmic correlation
within error, which is typically less than or equal to 20%.
Further demonstrated in Fig. 3 is a tradeoff between assay
time and sensitivity for this system. Exposing at times
allowing for incomplete conversion of monomer into
polymer has the ability to shift the sensitivity of the system,
as 5 min of exposure shifts the sensitivity back to 2,200
biotin markers/μm
2. Such tunability allows the user to
implement optimal assay conditions depending on the
required sensitivity of the application.
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target concentrations is directly due to the corresponding
increase of photoinitiator surface concentration on binding
withSA-EITC.With ahigher photoinitiatorconcentrationon
the surface, an increased number of propagating radical
chains are generated during the polymerization process.
Such free radicals are capable of diffusing from the surface
and through the forming polymer film, thereby increasing
the conversion of monomer into surface-bound polymer and
ultimately increasing film thicknesses. This trend is consis-
tent with both modeling and experimental findings of similar
systems in the literature [22]. After the polymerization
reaches high conversions, radical diffusivity throughout the
hydrogel membrane decreases and eventually limits the
extent of the polymerization. This results in the saturation
of film thicknesses at spots containing higher concentra-
tions of targets.
Competitive binding to tune regions of quantitative
amplification
The dynamic dependence of the film thickness on photo-
initiator surface concentration allows for an additional method
oftuning the sensitivityand dynamic amplification of thisassay
to concentration regions of interest. By varying the binding
parameters on the surface, allocation of different amounts of
photoinitiator to sites containing a constant amount of biotin
target is achievable. This potentially gives the user the ability to
detect and quantify biotinylated DNA concentrations that may
be either undetectable with less efficient binding or that may be
in a saturated region with more efficient binding.
A simple demonstration of this technique can be accom-
plished through the use of a competitive binding technique
involving incubating dilution chips with solutions containing
various ratios of unmodified SA with SA-EITC. Due to the
binding of unmodified SA to biotinylated DNA, the
concentration of biotinylated DNA available for binding
with SA-EITC decreases with higher SA to SA-EITC ratio.
Because eosin fluoresces upon excitation with a 532 nm
excitation source, a microarray scanner can be used to
quantify the amount of SA-EITC binding on dilution chips
incubated at various SA to SA-ETIC ratios. As shown in
Fig.4a, a shift towards lower fluorescent intensities and thus
lower photoinitiator surface densities at identical biotin
concentrations can be observed on dilution chips function-
alized with higher SA:SA-EITC ratios. This enables higher-
end spots with photoinitiator concentrations corresponding
to saturation from amplification without the addition of SA
to shift to concentrations spread over the quantifiable region
at higher SA:SA-EITC ratios. The result of this is a shift in
detection limits towards less sensitive detection, but also a
shift in the concentration regions of dynamic amplification,
as shown in Fig. 4b. Competitive binding allows for
quantification at higher-end concentrations ranging from
2,200–18,000 biotins/μm
2 and extends the overall quantifi-
able regions from 60 to 18,000 biotins/μm
2. Assuming
hybridization constants typical of complementary duplex
formation on microarray surfaces (Khyb=10
9 M
−1)[ 21] and
that each target sequence can be labeled with a single biotin
marker, the regions of quantification amplification corre-
spond to analyte concentrations in the nM to pM range.
In the case of detecting nucleic acid hybridization with
polymerization-based amplification, an alternative and
perhaps more feasible approach involves varying capture
sequence densities. The capture sequence density has been
shown both experimentally and through modeling consid-
erations to be a crucial parameter for achieving an optimal
signal from hybridization [23, 24]. In an effort to shift a
saturated response generated from complementary target-
capture hybridization to a quantifiable response, sites with
ab
Lower limit of 
quantifiable detection
= 60 targets/
Lower limit of quantifiable 
detection = 2200 targets/ µm2
µm2
Fig. 3 a Fluorescent micro-
scope image of a dilution chip
amplified at 10 mW/cm
2,3 0
min, followed by coupling rho-
damine molecules to polymer
films to enhance the visibility of
the spots (reverse grayscale).
The lowest concentration of tar-
gets that consistently produced
polymer films with measurable
thicknesses was 60 targets/μm
2
(circled in the figure). Lower
concentrations produced visual-
ly detectable polymer films but
were not measurable with pro-
filometry. b Corresponding
polymer film thicknesses versus
labeled oligonucleotide surface
density for two different expo-
sure times
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Such sites would then render lower photoinitiator concen-
trations than optimal sites at the same target concentrations,
potentially shifting a saturated response to a quantifiable
response. With the high-throughput capability of DNA chips,
several sites of identical complementary capture sequences
couldbeprintedatoptimalandsuccessivelylessthanoptimal
conditions within a single array, allowing for a quantifiable
response to be achieved over many orders of magnitude.
Coupling amplified fluorescent signal with polymer growth
To implement inexpensive detection instrumentation for
quantification, it is essential that PEG films with quantita-
tive thicknesses generated from polymerization-based am-
plification be correlated with a measurable signal consistent
with inexpensive methods of characterization. Direct film
thickness measurements at the nanometer level are gener-
ally unfeasible in clinical settings due to the expense of the
necessary instrumentation (profilometry, ellipsometry,
atomic force microscopy). However, developing this am-
plification system in order to aim to generate an amplified
fluorescent signal that corresponds with film thickness is
particularly desirable, due to the numerous types of instrumen-
tation available for characterizing biomolecule interactions
using fluorescence measurements [25]. For array-based
biosensors, such instrumentation ranges from microarray
scanners using photomultiplier tube (PMT) detectors
(detection limit < 0.05 fluors/μm
2,1 0
6 dynamic range)
[26], costing hundreds of thousands of dollars, to inexpen-
sive, portable fluorescence readers employing detection
with less-sensitive complementary metal oxide semicon-
ductor or charged coupled device (CCD) detectors that are
more amenable to point-of-care testing. With these consid-
erations in mind, an initial demonstration of the use of
polymerization-based amplification to achieve an amplified,
quantitative fluorescent signal is demonstrated herein.
The preferred approach to coupling fluorescent signal
with polymer growth is to include the fluorescent moiety in
the monomer formulation such that it is copolymerized or
encapsulated into the crosslinked polymer network. With
the commercial availability of several acrylated fluoro-
phores, copolymerization of molecules such as fluorescien-
o-acrylate into PEG-based polymer films on a solid
substrate has been demonstrated as a method of coupling
a fluorescent response to hydrogel formation [27]. When
applied to photopolymerization-based amplification, limi-
tations to such approaches are inherent, namely: nonspecif-
ic initiation of the bulk monomer due to photoreduction
reactions occurring between photoexcited fluorophores and
amine coinitiators; decreased initiation rates from the
surface-bound eosin initiators due to light attenuation to
the surface caused by the absorbing fluorophore; and
finally, saturation of the fluorescent signal after amplifica-
tion due to the quenching of fluorescent molecules at higher
concentrations. An alternative to fluorescent acrylates are
commercially available 20-nm-diameter polystyrene micro-
spheres that encapsulate large numbers of fluorophores per
particle. These fluorescent particles mitigate many of the
above limitations, largely due to the fact that they minimize
fluorophore contact with their surrounding environment and
remain strongly fluorescent.
Fig. 4 a Fluorescent intensity profiles on dilution chips before
amplification using competitive binding assay at various SA-EITC to
SA ratios. b Corresponding film thicknesses from polymerization-
based amplification for each SA-EITC:SA ratio (30 min exposure).
Points with saturated thicknesses are not shown on the plot
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tion-based amplification, 20-nm-diameter Nile Red (532/
575) FluoSpheres (ɛ532=2.3×10
6 cm
−1 M
−1) were added to
monomer solution at various concentrations. Figure 5
shows the absorbance spectra of the monomer solution
containing 90 nM fluorescent nanoparticles compared to
that of a 10 μg/mL solution of SA-EITC. There is a con-
siderable overlap in absorbance between the monomer
solution and the initiator at wavelengths in the 500–650 nm
region used to initiate the polymerization reaction. Thus,
adsorption of light from fluorescent monomer effectively
decreases initiation rates from SA-EITC at constant light
intensity. This effect is observed when monitoring bulk
polymerization kinetics under initiation conditions similar to
those used during on-chip amplification. The monomer
conversion into polymer with time is shown in Fig. 6 using
85 μg/mL SA-EITC (equivalent to 2 μM eosin), a concentra-
tion representing the local concentrations of SA-EITC
typically obtained over positive spots on the dilution chips
containing dilute amounts of biotin. Both the polymeriza-
tion kinetics and the final conversion of monomer to
polymer decrease due to the addition of nanoparticles. The
decrease in final conversion suggests that nanoparticles may
be capable of terminating propagating free radicals during
the polymerization process.
An important observation from Fig. 6 is that without the
addition of SA-EITC to monomer, polymerization is only
observed at long exposure times (greater than 40 min, shown
in curve d of Fig. 6). Photoinitiation due to photoexcited
fluorescent nanoparticles at nanomolar concentrations is
thus considerably less efficient than initiation from SA-
EITC. This exposure window where polymerization occurs
exclusively from SA-EITC allows for specificity in the
amplification. Upon applying this system to a surface-
initiated polymerization on dilution chips, polymerization
at lower exposure will only occur due to the presence of
SA-EITC from biotin–avidin binding. Unwanted, non-
specific initiation from the fluorescent nanospheres with
bulk monomer does not occur until much longer exposure
times. Thus, at lower exposures, the fluorescent monomer
formulation is amenable to on-chip signal amplification in
order to obtain amplified fluorescent signals.
Finally, amplification using monomer solutions contain-
ing nanomolar concentrations of Nile Red FluoSpheres from
SA-ETIC-functionalized dilution chips were performed. At a
diameter of 20 nm, the nanospheres are either encapsulated
or covalently linked into the PEGDA hydrogel matrix, and
are not released during washing steps. Figure 7 details the
increase in fluorescent signal from the amplification. The
last seven columns corresponding to the seven higher-end
biotin surface concentration points show an amplified,
quantifiable fluorescent signal, and the highest gains are
achieved with the nanoparticles used at 500 nM concen-
trations in monomer. The number of encapsulated nano-
spheres and the corresponding fluorescent intensity
increase monotonically with film thickness after amplifi-
cation on dilution chips. This results in a large gradient
in fluorescent signal ranging from 50 to 8000 Cy3
Fig. 6 FTIR plot of carbon–carbon double bond conversion of
monomer (25% (wt/vol) PEGDA, 225 mM MDEA, 37.5 mM 1-
vinyl-2-pyrrolidinone, pH 9.0) versus time at different concentrations
of fluorescent nanoparticles and photoinitiator using a 495–650-nm
light source at 10 mW/cm
2. a,2μM eosin (85 μg/mL SA-EITC),
0 nM fluorescent nanoparticles. b,2μM eosin, 90 nM fluorescent
nanoparticles. c,2μM eosin, 480 nM fluorescent nanoparticles. d,
0 μM SA-EITC, 480 nM fluorescent nanoparticles. e,0μM SA-EITC,
0 nM fluorescent nanoparticles
Fig. 5 Absorbance from SA-EITC product used to initiate the
polymerization-based amplification and from fluorophores encapsu-
lated in 20-nm polystyrene nanospheres and diluted to 90 nM in
PEGDA monomer formulation
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2, corresponding linearly to the number of biotin–
SA-EITC binding events generating the signal.
Moreover, the gain in fluorescent signal achieved through
the amplification allows for the characterization of the
biotinylated DNA concentrations using less sophisticated
instrumentation amenable to point-of-care settings. Prior to
amplification, SA-EITC-functionalized dilution chips were
only detectable using a microarray scanner employing a
PMT detector with low detection limits measured at
0.28 Cy3 fluors/μm
2. After the amplification, the last six
columns on the dilution chip were characterized using a
stereomicroscope containing a CCD camera: a considerably
less expensive, less sophisticated instrument with higher
detection limits, measured at 570 Cy3 fluors/μm
2.
The results presented represent an initial demonstration of
the use of polymerization-based amplification to supply
amplified, quantitative fluorescent signals useful for the
measurement of DNA surface concentrations. Currently, the
addition of the fluorescent nanoparticles decreases polymer
film thicknesses and thus decreases the sensitivity of the assay
as compared to amplification without their inclusion. This is
consistent with the decrease in final conversions of bulk
polymerizations with higher concentrations of nanoparticles
n o t e di nF i g .6. Work is currently underway to obtain thicker
polymer films containing higher concentrations of nano-
particles, allowing for higher gains in fluorescent signal
and increased sensitivity with quantitative capability. Such
advancements will further the use of polymerization-based
amplification for quantitative applications.
Conclusion
Polymerization-based amplification has the ability to pro-
vide quantitative evaluation of genetic biomarkers over at
least two orders of magnitude, as demonstrated through film
thickness measurements correlating to the surface concen-
trations of biotinylated DNA targets. The photoinitiator
surface density is a critical parameter in determining the
amount of polymer growth observed from the surface, as this
parameter can be manipulated depending on binding con-
ditions to tune the amount of amplification generated from a
given number of biotinylated targets localized on a biosensor
surface. This amplification system is amenable to obtaining
an amplified fluorescent response correlating with film
b
Stereomicroscope detection limit 
Increasing biotin-SA-EITC binding events/µm
2
a
c
= 570 Cy3/µm
2
Fig. 7 a Stereomicroscope images of dilution chips before amplifi-
cation (top)a n da f t e ra m p l i f i c a t i o n( bottom) using fluorescent
monomer solution (spots printed in triplicate). b Film thicknesses
versus fluorescent signal generated from encapsulated fluorescent
nanospheres after inclusion in monomer at 90 or 500 nM concen-
trations. c Measured fluorophore densities versus biotin–SA-EITC
binding events after polymerization-based amplification
R
174 R. Hansen et al.thickness, enabling the evaluation of biomarker quantities
with less expensive instrumentation.
The large, dynamic variation in film thicknesses and
amplified fluorescent signal obtained from polymerization-
based amplification opens up many potential uses for this
assay that were previously unachievable from only a positive/
negative response. For example, polymer growth arising from
nonspecific biomolecule interactions can be characterized as
background amplification such that only a deviation from this
background becomes significant. This means that polymeri-
zation-based amplification can potentially be used in applica-
tions where both high specificity and sensitivity are critical,
such as in a high-throughput SNP screening. Similarly,
markers that become significant only when deviating from
characterized background levels can also be analyzed. This is
the case for the majority of proteomic biomarkers, and
currently work is underway aimed at extending this assay to
the detection of antigen–antibody binding.
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